Why not just make it an annual mandatory thing? Or maybe biannual?
The CEO of BioNTech SE — the German biotechnology company that developed the first COVID-19 vaccine in a partnership with Pfizer — said a new coronavirus vaccine would likely be needed next year.
Ugur Sahin — co-founder and chief executive officer of BioNTech — told the Financial Times on Sunday that a new COVID-19 formula could be necessary by mid-2022 to combat new strains of coronavirus that evade booster shots and the body’s immune defenses. Sahin also stressed that the new vaccine isn’t needed at the moment because he claims that the current COVID-19 vaccine is effective against the delta variant.Recommended VideosPowered by AnyClipRand Paul GRILLS Biden Nominee into Complete Embarrassment on COVID54.8K108Play Video
“This year [a different vaccine] is completely unneeded,” Sahin said. “But by mid next year, it could be a different situation.”
- New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality
- MIT Scientist Warns About Covid Vaccine on the Brain
- Wait. What? Pfizer CEO now says 2 COVID shots “offers very limited protection, if any,” against COVID-19.
- BREAKING: Biden Administration Making Lists of Religious Vaccine Objectors
- Inside the January 6th Setup– Who is Ray Epps?
- SCOTUS Ruling on OSHA mandate expected today
- Teacher alleges she was fired for not ‘meowing’ back at student who identifies as a cat
- Professor Absolutely Loses it on Zoom. (NSFW) “You are all just vectors of disease to me!”
- Insane — Canada court rules father cannot criticize COVID vaccines around 10-year-old son
- Tyranny — New infrastructure bill grants U.S. gov’t ability to disable vehicles remotely